For research use only. Not for therapeutic Use.
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1].
| Catalog Number | I043781 |
| CAS Number | 1644539-04-7 |
| Purity | ≥95% |
| Reference | [1]. Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739. |
